Cargando…

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies

Myeloid malignancies arise from an altered hematopoietic stem cell and mainly comprise acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative malignancies, and chronic myelomonocytic leukemia. Myeloid neoplastic leukemic cells may influence the growth and differentiation of other hema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapor, Suncica, Santibanez, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268878/ https://www.ncbi.nlm.nih.gov/pubmed/34202907 http://dx.doi.org/10.3390/jcm10132788

Ejemplares similares

Mesenchymal stromal cells in myeloid malignancies
por: Schroeder, Thomas, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
por: Bizymi, Nikoleta, et al.
Publicado: (2019)

Hydroxyurea Induces Bone Marrow Mesenchymal Stromal Cells Senescence and Modifies Cell Functionality In Vitro
por: Kapor, Sunčica, et al.
Publicado: (2021)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
por: Papafragkos, Iosif, et al.
Publicado: (2021)

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019)

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation
por: Vladimirovna, Irina Lyadova, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
por: Lv, Meng, et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
por: Veglia, Filippo, et al.
Publicado: (2021)

Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?
por: Kapor, Sunčica, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
por: Yu, Shunjie, et al.
Publicado: (2022)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
por: Bryant, Andrew J., et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
por: Bhardwaj, Vaishali, et al.
Publicado: (2023)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

The role of myeloid‐derived suppressor cells in gastrointestinal cancer
por: Cui, Cheng, et al.
Publicado: (2021)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells for cancer therapy
por: Tang, Hongchao, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
por: Kim, Yeon-Jeong, et al.
Publicado: (2015)

Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
por: Damuzzo, Vera, et al.
Publicado: (2015)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

The role of myeloid-derived suppressor cells in liver cancer
por: Zhou, Shiyue, et al.
Publicado: (2023)

Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles
por: Bayik, Defne, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms
por: Vukotić, Milica, et al.
Publicado: (2022)

Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells
por: Tan, Zhenya, et al.
Publicado: (2022)

Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
por: Zhang, Weitao, et al.
Publicado: (2018)

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients
por: Giallongo, Cesarina, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
por: Katoh, Hiroshi, et al.
Publicado: (2015)

The emerging role of myeloid-derived suppressor cells in radiotherapy
por: Kang, Changhee, et al.
Publicado: (2020)

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
por: Tian, Xinyu, et al.
Publicado: (2019)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Myeloid-derived suppressor cells: Cellular missiles to target tumors
por: Chandra, Dinesh, et al.
Publicado: (2013)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_62k2ui6m17b7q88ai9p8a59el0